Antimicrobial resistance of clinical and environmental strains of Vibrio cholerae isolated in Lima-Peru during epidemics of 1991 and 1998

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 1, 2007, Pages 100-105

  Ibarra, J O ^a   Alvarado, D E ^b  

^a UNIVERSIDAD NACIONAL FEDERICO VILLARREAL   (Peru)

^b UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

Author keywords

Antimicrobial resistance; Cholera outbreak; Vibrio cholerae

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; FURAZOLIDONE; NALIDIXIC ACID; STREPTOMYCIN; SULFAMETHIZOLE; SULFATRIMETHOPRIM; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHEMICAL ANALYSIS; CHOLERA; DIFFUSION; DRUG SENSITIVITY; EPIDEMIC; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERU; SEROLOGY; STRAIN IDENTIFICATION; TAXONOMY; VIBRIO CHOLERAE;

EID: 34347383206     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000100022     Document Type: Article

References (34)

1. Bennish M. Cholera: Pathophysiology, Clinical, Features, and Treatment. Ch 15. In: Wachsmuth I.K., Blake P.A., Olsvik Ô. eds.Vibrio cholerae and Cholera - Molecular to global perspectives. Washington D.C.: American Society for Microbiology, 1994.
2. Yamai S., Okitsu T., Shimada T., Katsube T. Distribution of serogroups of Vibrio cholerae Non-O1, Non-O139 with specific reference to their ability to produce cholera toxin and addition of novel serogroups. Kansenshogaku-Zasshi 1997;71:1037-45.
3. Seas C., Gotuzzo E. Vibrio cholerae and other species. In: Yu V., Merigan T. Jr., Barriere S. ed. Antimicrobial Therapy and Vaccines. Baltimore, USA: Williams & Wilkins, 1999.
4. Cavallo J., Niel L., Talarmin A., Dubrous P. Sensibilité aux antibiotiques de souches epidemiques de Vibrio cholerae et Shigella dysenteriae isolées dans les camps de refugiés rwandais aun Zaire. Med Trop Mars 1995;55:351-3.
5. Sathiyamurthy K., Purushshotaman A., Ramaiyan V. Antibiotic resistant of Vibrio cholerae in Parangipetti coastal environs, south east India. Microb Drug Resist 1997;3:267-70.
6. Holt J.G., Krieg N.R., Sneath P.H.A., et al. eds. Bergey's Manual of Determinative Bacteriology. Maryland, USA: Willliams & Wilkins, 1994.
7. Hug A. Alam M., Parveen S., Colwell R. Occurrence of resistance to vibriostatic O/129 in Vibrio cholerae O1 isolated from Clinical and environmental samples in Bangladesh. J Clin Microbiol 1992; 30:219-21.
8. Abbot S., Cheung W., Portoni B., Janda M. Isolation of vibriostatic agent O/129-resistance Vibrio cholerae Non-O1 from a patient with gastroenteritis. J Clin Microbiol 1992;30:1598-99.
9. Ramamurthy T., Pal A., Pal S. Nair G. Taxonomical implications of the emergence of high frequency of occurrence of 2,4-diamino-6,7-diisopropylpteridine-resistant strains ofVibrio cholerae from clinical cases of cholera in Calcutta, India. J Clin Microbiol 1992;30:742-3.
10. Korichi M., Belchocine S., Rahal K. Plasmides inc J identifies pour la premiere fois dans Vibrio cholerae El Tor. Med Trop Mars 1997;57:249-52.
11. Sow A., Cisse M., Gaye M., et al. Diversité bacterienne au cours de l'epidemie de cholera a Dakar, Senegal (1995-1996). Bull Soc Pathol Exot 1997;90:160-1.
12. Ministerio de Salud/Oficina de Defensa Nacional/OPS. Cap 11: Perú. En: Crónica de desastres-Fenómeno El Niño, 1997-1998. Washington, DC, USA: OPS, 2000.
13. Gotuzzo E., Cieza J., Estremadoyro L., Seas C. Cholera. Lessons from the Epidemic in Perú. Infect Dis Clin North Am 1994;8:183-205.
14. Ibarra J., Delgado A., Alvarado D. Vibrios no epidémicos y Vibrio cholerae O1 asociados a Enfermedad Diarreica Aguda Evento Climatológico "El Niño" 1998 - Hospital Dos de Mayo. Revista Anales Facultad Medicina 1999;60:251-6.
15. Clendenes M., Carballo F., Huaroto L., et al. Epidemic outbreak of acute diarrhea disease in adults in a emergency room. Resumen PS 048, Proc. 24th International Congress of Internal Medicine. International Society of Internal Medicine. Lima-Perú 1998.
16. UNESCO/MIRCEN/FAO/UNEP/IUMS/UNIV.MARYLAND. Workshop schedule. International Workshop on Environmental and Aquatic Microbiology and Biotechnology. Maryland, USA: University of Maryland, 1993.
17. Bauer A., Kirby W., Sherris J., Turck M. Antibiotic susceptibility testing by a standarized sing disk method. Am J Clin Pathol 1966; 45:493-6.
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 4th ed. Approved stand. NCCLS document M100-54. Pennsylvania, USA: NCCLS, 1992.
19. National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobial susceptibility testing; Fourteenth informational supplement. NCCLS document M100-S14. Pennsylvania, USA: NCCLS, 2004.
20. Kay B.A., Bopp C.A., Wells J.G. Isolation and Identification of Vibrio cholerae O1 from fecal specimens. Ch 1. In: Wachsmuth I.K., Blake P..A, Olsvik Ô. Eds. Vibrio cholerae and Cholera - Molecular to global perspectives. Washington DC, USA: American Society for Microbiology, 1994.
21. Manning P., Stroeher M.R. Molecular basis for O-antigen biosynthesis in Vibrio cholerae O1: Ogawa-Inaba switching. Ch 6. In: Wachsmuth I.K., Blake P. A., Olsvik Ô., ed. Vibrio cholerae and cholera - Molecular to global perspectives. Washington DC, USA: American Society for Microbiology. 1994.
22. Colwell R., Epstein P., Gubler D., et al. Global climate change and infections diseases. Emerg Infect Dis 1998;4:451-2.
23. Ministerio de Salud-Perú. Análisis epidemiológico de las enfermedades vigiladas por la Red Nacional de Epidemiología - I Semestre. Boletín Epidemiológico 1999;2:3-7.
24. Ramamurthy T., Pal A., Pal S., Nair G. Taxonomical implications of the emergence of high frequency of occurrence of 2,4-diamino-6,7-diisopropylpteridine-resistant strains of Vibrio cholerae from clinical cases of cholera in Calcutta, India. J Clin Microbiol 1992;30:742-3.
25. Falbo V., Carattoli A., Tosini F., et al. Antibiotic Resístanse Conferred by a Conjugative Plasmid and a Class I Integron in Vibrio cholerae O1 El Tor Strains Isolated in Albania and Italy. Antimicro Agent Chemotherapy 1999;43:693-6.
26. Albert M., Bhuiyan N., Talukder K., et al. Phenotypic and genotypic changes in Vibrio cholerae O139 Bengal. J Clin Microbiol 1997;35:2588-92.
27. Ibarra J.O., Alvarado D.E. Evaluación de la resistencia a 2,4-Diamino-6,7-Diisopropilpteridina en estirpes de Vibrio cholerae aisladas durante el ENOS 98 de muestras clínicas y ambientales. En: Libro de resúmenes del Seminario Taller: Impacto de los eventos "El Niño Oscilación Sur" sobre la diversidad biológica de América Latina. Lima, Perú: CONCYTEC-RIBEN, 1999.
28. Podosinnikova L., Mazrukho B., Lomov I., et al. Nekotoye osobennosti Vibrio cholerae, vydelennykh v Dagestane v 1994 g. Zh Mikrobiol. Epidemiol. Immunol 1995;2:74-8.
29. Doganci L., Gun H., Baysallar M., et al. Short- term quinolonas for successful erradication of multiply resistant Vibrio cholerae in adult patients. Scand. J Infect Dis 1995;27:425-6.
30. Gotuzzo E., Seas C., Echevarria J., et al. Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults Clin Infect Dis 1995;20:1485-90.
31. Yamamoto T., Nair G., Albert M., et al. Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents. Antimicrob Agents Chemother 1995;39:241-4.
32. Korichi M., Belchocine S., Rahal K. Plasmides inc J identifies pour la premiere fois dans Vibrio cholerae El Tor Med Trop Mars 1997;57:249-52.
33. Ibarra J., Flores L., García R., Alvarado D. Estudio preliminar de la resistencia de V.cholerae O1, brote epidémico 1998, a antimicrobianos. Revista Peruana de Biologia 2000;7:83-6.
34. Gil A.I., Louis V.R., Rivera I.N.G., et al. Occurrence and distribution of Vibrio cholerae in the coastal environment of Peru. Environ Microbiol 2004;6:699.